Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Future Sci OA ; 10(1): FSO953, 2024.
Article in English | MEDLINE | ID: mdl-38817363

ABSTRACT

Aim: We analyzed the 100 most-cited articles on all anti-diabetic drugs. A comprehensive literature review found no bibliometrics on this. Methods: Two researchers independently extracted articles from Scopus and ranked them by citation count as the 'top 100 most-cited'. Results: The median number of citations is 1385.5. Most articles are from the USA (n = 59). Insulin has the most papers (n = 24). Majority (n = 76) were privately funded and contained at least one conflict of interest (n = 66). The New England Journal of Medicine has the most publications (n = 44). Male authors made majority of both first and last authorship positions. Conclusion: This study aims to aid in directing future research and in reducing biases.

2.
Curr Probl Cardiol ; 49(1 Pt C): 102148, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37863458

ABSTRACT

There is a lack of mortality data on rheumatic heart disease (RHD) in the United States (US). In light of this, a retrospective analysis was conducted to investigate the temporal, sex-based, racial, and regional trends in RHD-related mortality in the US, ranging from 1999 to 2020. The Center for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC-WONDER) dataset was analyzed, where crude and age-adjusted mortality rates (AAMR) were identified, along with annual percentage changes (APCs) determined by Joinpoint regression. Through the period of 1999 to 2020, there were 141,137 RHD-related deaths reported, with a marginal decline from 4.05/100,000 in 1999 to 3.12/100,000 in 2020. However, the recent rise in AAMR from 2017 to 2020 has created a source of concern (APC: 6.62 [95% CI, 3.19-8.72]). Similar trends were observed in the Black or African American race from 2017 to 2020 (APC: 10.58 [95% CI, 6.29-17.80]). Moreover, the highest percentage change from 2018 to 2020 was observed in residents of large metropolitan areas (APC: 7.6 [95% CI, 2.8-10.5]). A prominent disparity was observed among states, with values ranging from 1.74/100,000 in Louisiana to 5.27/100,000 in Vermont. States within the top 90th percentile of RHD-related deaths included Alaska, Minnesota, Washington, Wyoming, and Vermont. In conclusion, it is imperative to delve deeper into the evidently rising trends of RHD-related mortality and outline the possible sources of social determinants within US healthcare in order to provide equal and quality medical care throughout the nation.


Subject(s)
Rheumatic Heart Disease , Humans , Racial Groups , Retrospective Studies , Rheumatic Heart Disease/mortality , United States/epidemiology , Male , Female
3.
PLoS Pathog ; 19(12): e1011888, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38113281

ABSTRACT

Bacterial pathogens exhibit a remarkable ability to persist and thrive in diverse ecological niches. Understanding the mechanisms enabling their transition between habitats is crucial to control dissemination and potential disease outbreaks. Here, we use Ralstonia solanacearum, the causing agent of the bacterial wilt disease, as a model to investigate pathogen adaptation to water and soil, two environments that act as bacterial reservoirs, and compare this information with gene expression in planta. Gene expression in water resembled that observed during late xylem colonization, with an intriguing induction of the type 3 secretion system (T3SS). Alkaline pH and nutrient scarcity-conditions also encountered during late infection stages-were identified as the triggers for this T3SS induction. In the soil environment, R. solanacearum upregulated stress-responses and genes for the use of alternate carbon sources, such as phenylacetate catabolism and the glyoxylate cycle, and downregulated virulence-associated genes. We proved through gain- and loss-of-function experiments that genes associated with the oxidative stress response, such as the regulator OxyR and the catalase KatG, are key for bacterial survival in soil, as their deletion cause a decrease in culturability associated with a premature induction of the viable but non culturable state (VBNC). This work identifies essential factors necessary for R. solanacearum to complete its life cycle and is the first comprehensive gene expression analysis in all environments occupied by a bacterial plant pathogen, providing valuable insights into its biology and adaptation to unexplored habitats.


Subject(s)
Ralstonia solanacearum , Solanum lycopersicum , Animals , Life Cycle Stages , Soil , Water/metabolism , Gene Expression , Plant Diseases/genetics , Plant Diseases/microbiology , Ralstonia solanacearum/genetics , Ralstonia solanacearum/metabolism
4.
5.
Am J Cardiol ; 199: 85-91, 2023 07 15.
Article in English | MEDLINE | ID: mdl-37269781

ABSTRACT

Mineralocorticoid receptor antagonists (MRAs) are known to improve clinical outcomes in heart failure, particularly heart failure with reduced ejection fraction. However, the effect of MRAs on the incidence of and recurrence of atrial fibrillation (AF) is not well established. Therefore, databases, such as PubMed, EMBASE, and Cochrane Central, were searched from inception to September 2021 for randomized controlled trials of MRAs with AF as an outcome. Risk ratios (RRs) with 95% confidence interval (CIs) were combined using the random-effects model. A total of 10 randomized controlled trials (n = 11,356) were included. Our pooled analysis demonstrates that MRAs reduce the risk of AF occurrence by 23% compared with the control therapy (RR 0.77, 95% CI 0.65 to 0.91, p = 0.003, I2 = 40%). Subgroup analysis demonstrated that MRAs reduced the risk of both new-onset AF (RR 0.84, 95% CI 0.61 to 1.16, p = 0.28, I2 = 43%) and recurrent AF (RR 0.73, 95% CI 0.59 to 0.90, p = 0.004, I2 = 26%) similarly; p interaction = 0.48. Our meta-analysis concludes that MRAs reduce the risk of development of AF overall, with consistent effects in new-onset and recurrent AF.


Subject(s)
Atrial Fibrillation , Heart Failure , Humans , Mineralocorticoid Receptor Antagonists/therapeutic use , Atrial Fibrillation/epidemiology , Atrial Fibrillation/drug therapy , Heart Failure/epidemiology , Heart Failure/prevention & control , Heart Failure/drug therapy , Incidence , Odds Ratio
6.
Curr Probl Cardiol ; 48(4): 101582, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36584726

ABSTRACT

The effect of Sodium-glucose cotransporter-2 (SGLT2) inhibitors on the occurrence of AF and stroke remains unclear due to underpowered individual studies. We aim to conduct a meta-analysis including all studies that have evaluated the effects of SGLT2 inhibitors on the occurrence of AF and stroke. We queried electronic databases (PubMed, Cochrane CENTRAL and ClinicalTrials.gov) for randomized controlled trials assessing the effect of SGLT2 inhibitors. Trials were selected if they reported 1 or both of the pre-specified outcomes of stroke and AF. Results were pooled using a random-effects model. Subgroup analysis was conducted to study patients with T2DM, HF, CVD and CKD. 56 trials comprising 111,773 patients were included. SGLT2 inhibitors significantly reduced the incidence of AF across all studies (RR:0.87; 95%CI, [0.76-0.99], P=0.03, I^2=0%) especially when used as monotherapy (RR:0.87; 95%CI, [0.77-0.99], P=0.04, I^2=0%) and among T2DM patients (RR:0.83; 95%CI, [0.72-0.97], P=0.02, I^2=0%). The risk of stroke was not reduced after treatment with SGLT2 inhibitors (RR:0.97; 95%CI, [0.89-1.07], P=0.56, I^2=0%) and this was consistent when given as monotherapy (RR:0.98; 95%CI, [0.89-1.07], P=0.62, I^2=0%) or combination therapy (RR:0.58; 95%CI, [0.17-1.95], P=0.38, I^2=0%). This result was consistent among the 3 subpopulations: T2DM, CVD and HF, however benefit was seen in patients with CKD (eGFR<90) (RR:0.85; 95%CI, [0.75-0.97], P=0.02, I^2=0%). SGLT2 inhibitors significantly reduce the incidence of atrial fibrillation, and this effect is primarily seen when given as monotherapy and in patients with T2DM. However, they have no significant effect on the incidence of stroke, except for in patients with Stage 2 CKD and beyond (eGFR<90).


Subject(s)
Atrial Fibrillation , Diabetes Mellitus, Type 2 , Renal Insufficiency, Chronic , Sodium-Glucose Transporter 2 Inhibitors , Stroke , Symporters , Humans , Sodium-Glucose Transporter 2 Inhibitors/adverse effects , Diabetes Mellitus, Type 2/epidemiology , Glucose , Sodium
7.
Personal Ment Health ; 16(3): 217-234, 2022 08.
Article in English | MEDLINE | ID: mdl-34866357

ABSTRACT

A significant proportion of those with eating disorders (EDs) do not respond to first-line treatments. This systematic review was conducted to identify whether personality disorders (PDs)/traits predict or moderate ED treatment outcomes and whether these outcomes were differentially influenced by ED or PD diagnostic subtypes, or treatment approach. A comprehensive systematic literature search was conducted using the PRISMA guidelines. A total of seven randomised controlled trials (RCTs) plus four follow-up studies were reviewed investigating the impact of PD and PD traits on treatment outcomes for EDs. The majority indicated that PD had some impact on treatment outcomes. Outcome measures and time-point measurements varied across studies. Included studies suggested that bulimia nervosa treatment outcomes were not hindered by co-morbidity of borderline PD; however, psychiatric impairment remained high at post-treatment and follow-up. Cluster C PDs were found to negatively impact treatment outcomes for binge ED and attrition rates for anorexia nervosa. Included studies suggested that interventions that addressed aspects of personality pathology showed greater main effects for ED treatment outcomes. There is an urgent need for future RCTs on ED treatments to include routine measures of core personality features to allow their impacts to be more thoroughly examined and for psychotherapies to be tailored accordingly.


Subject(s)
Feeding and Eating Disorders , Personality Disorders , Feeding and Eating Disorders/therapy , Humans , Personality , Personality Disorders/diagnosis , Personality Disorders/therapy , Psychotherapy , Treatment Outcome
8.
Br J Soc Psychol ; 61(1): 214-252, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34155661

ABSTRACT

Intergroup contact is key to social cohesion, yet psychological barriers block engagement with diversity even when contact opportunities are abundant. We lack an advanced understanding of contact seeking because intergroup contact is often an independent variable in research, and studies on contact seeking have favoured experimental probing of selected factors or measured only broad behavioural intentions. This research carried out the first ecological tests of a novel multilayer-multivariate framework to contact seeking/avoiding. These tests were centred on a Muslim-led community contact-based initiative with visible support from local authorities following a terrorist attack. Non-Muslim Australian women (N = 1,347) contributed field data on their situated contact motivations, choices, and attendance at an intercultural educational stall; many (N = 559) completed a profiling test battery. Among those who responded to the initiative invite, the rate of taking up the high-salience contact opportunity in this heated setting was high and reflected multiple approach/avoidance motivations. Contact seeking/avoiding was not just allophilia/prejudice; it presented as new typologies of politicized solidarity, courage, apathy, and moral outrage. While intergroup predictors were significant across all profiling analyses, intrapersonal and interpersonal predictors also regularly contributed to explain variance in non-Muslims' contact motivations and choices, confirming their multilayer-multivariate nature.


Subject(s)
Apathy , Courage , Australia , Female , Humans , Interpersonal Relations , Islam , Morals , Prejudice , Social Cohesion
SELECTION OF CITATIONS
SEARCH DETAIL